Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
WO 2022177965
COMPOSITIONS NUTRITIONNELLES COMPRENANT DES OLIGOSACCHARIDES DU LAIT HUMAIN ET DE L'IMMUNOGLOBULINE BOVINE
granted -
US 11419875
Compounds and compositions for treating hematological disorders
granted -
US 11419869
Dosage forms and regimens for amino acid compounds
granted -
US 11419934
Use of VDAS to enhance immunomodulating therapies against tumors
granted -
US 11419888
Composition and method for promoting reduction of heat stress in animals
granted -
US 11419844
Halogenated xanthene composition and method for treating hematologic cancers
granted -
US 11419318
Genetically modified rat comprising a humanized TRKB locus
granted -
US 11419942
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
granted -
US 11419898
Combinatorial cancer immunotherapy
granted -
US 11421007
Zinc finger protein compositions for modulation of huntingtin (Htt)
granted -
US 11419949
Adeno-associated virus variant capsids and methods of use thereof
granted -
US 11419835
Method of treatment and prevention of bacterial vaginosis
granted -
US 11419883
Inhibiting senescent processes in beta cells for the prevention of type 1 diabetes
granted -
US 11419812
Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11420976
Heterocyclic compounds as anti-viral agents
granted -
US 11422132
Peptides and uses thereof for diagnosing and treating myasthenia gravis
granted -
US 11421021
Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and LukB derived polypeptides
granted -
US 11421010
T cells expressing membrane-anchored IL-12 for the treatment of cancer
granted -
US 11421231
Modulation of Huntington expression
granted -
US 11421034
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer
granted -
US 11421284
Methods for predicting drug responsiveness in cancer patients
granted -
US 11421036
Methods of treating eosinophilic esophagitis by administering an antibody which inhibits interleukin-4 receptor (IL-4R)
granted -
US 11420929
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
granted -
US 11420965
Pyrimidine compound as JAK kinase inhibitor
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.